This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Procter & Gamble Trades Above 50 & 200-Day SMAs: Buy Now or Wait?
by Rajani Lohia
PG drives growth through productivity and cost savings but faces headwinds from geopolitical tensions, currency volatility and challenges in key markets.
Procter & Gamble (PG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Procter & Gamble (PG) stood at $170.54, denoting a +0.18% change from the preceding trading day.
Why Is P&G (PG) Up 0.6% Since Last Earnings Report?
by Zacks Equity Research
P&G (PG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Trending Stock Procter & Gamble Company (The) (PG) a Buy Now?
by Zacks Equity Research
P&G (PG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Analyst Blog The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific
by Zacks Equity Research
The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific are included in this Analyst Blog.
Top Research Reports for Procter & Gamble, Boston Scientific & ConocoPhillips
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Boston Scientific Corporation (BSX) and ConocoPhillips (COP), as well as a micro-cap stock Kewaunee Scientific Corporation (KEQU).
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?
by Zacks Equity Research
Sector ETF report for IYK
Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?
by Zacks Equity Research
Sector ETF report for IYK
Should You Invest in the Vanguard Consumer Staples ETF (VDC)?
by Zacks Equity Research
Sector ETF report for VDC
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
P&G (PG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Company News for Jan 23, 2025
by Zacks Equity Research
Companies In The Article Are:CMA, PG, ALLY and APH
Procter & Gamble Stock Gains as Q2 Earnings & Sales Beat Estimates
by Zacks Equity Research
PG's Q2 results reflect robust organic sales rise, core EPS growth and strong cash returns to shareholders. It remains on track to reach its fiscal 2025 view.
Leading Indicators Data in Focus
by Zacks Equity Research
Leading Indicators Data in Focus
Pre-Markets Keep Optimistic, Earnings Beats for JNJ, PG, ALLY & More
by Mark Vickery
Pre-market futures are picking up where they left off Tuesday afternoon: higher.
P&G (PG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for P&G (PG) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Procter & Gamble (PG) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 1.08% and 1.33%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Q4 Earnings: 3 Consumer Staples Titans on Deck
by Derek Lewis
Among the bunch of companies expected to report in the coming days include a few consumer staples titans such as Procter & Gamble, Johnson & Johnson, and Kimberly-Clark.
Big Trading Day Ends with Q4 Earnings Beats: NFLX, UAL, COF
by Mark Vickery
Indexes have rocketed up from 2025 lows hit a week to a week and a half ago.
A New U.S. Presidency Begins: Global Week Ahead
by John Blank
Trump's inauguration on Jan. 20th as the 47th U.S. president will likely bring with it a Day One-barrage of executive orders on anything from taxes to tariffs.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
P&G (PG) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for P&G (PG), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Procter & Gamble Stock: A Buy Opportunity Before Q2 Earnings?
by Rajani Lohia
PG's Q2 results should benefit from brand strength and solid strategies, offset by issues in Greater China, geopolitical tensions and currency volatility.
Procter & Gamble (PG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Rises Higher Than Market: Key Facts
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $159.74, moving +0.57% from the previous trading session.